New approach to adding study drug to chemo for melanoma treatment
Thursday, February 24, 2011 - 18:30
in Health & Medicine
Researchers at Duke University Medical Center have just completed a clinical trial that showed it is possible to study a new combination of drugs against a melanoma recurrence that has not spread beyond a limb. Using a fairly new technique called isolated limb infusion (ILI), they tested an additional drug, called ADH-1, along with a melanoma chemotherapy drug, melphalan. They tried the ADH-1 in an effort to see if this would improve patients antitumor responses.